These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31468706)

  • 41. LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.
    Spillmann F; Van Linthout S; Miteva K; Lorenz M; Stangl V; Schultheiss HP; Tschöpe C
    Atherosclerosis; 2014 Jan; 232(1):1-9. PubMed ID: 24401210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia-reperfusion injury.
    Lei P; Baysa A; Nebb HI; Valen G; Skomedal T; Osnes JB; Yang Z; Haugen F
    Basic Res Cardiol; 2013 Jan; 108(1):323. PubMed ID: 23266787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity.
    Karaboga H; Huang W; Srivastava S; Widmann S; Addanki S; Gamage KT; Mazhar Z; Ebalunode JO; Briggs JM; Gustafsson JÅ; Filgueira CS; Gilbertson SR; Lin CY
    ACS Chem Biol; 2020 Nov; 15(11):2916-2928. PubMed ID: 33074669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic Responses.
    Karpel-Massler G; Ishida CT; Bianchetti E; Shu C; Perez-Lorenzo R; Horst B; Banu M; Roth KA; Bruce JN; Canoll P; Altieri DC; Siegelin MD
    Cancer Res; 2017 Jul; 77(13):3513-3526. PubMed ID: 28522750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
    Kim HJ; Yoon KA; Yoon HJ; Hong JM; Lee MJ; Lee IK; Kim SY
    J Leukoc Biol; 2013 Jul; 94(1):99-107. PubMed ID: 23657115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacologic Activation of LXR Alters the Expression Profile of Tumor-Associated Macrophages and the Abundance of Regulatory T Cells in the Tumor Microenvironment.
    Carbó JM; León TE; Font-Díaz J; De la Rosa JV; Castrillo A; Picard FR; Staudenraus D; Huber M; Cedó L; Escolà-Gil JC; Campos L; Bakiri L; Wagner EF; Caelles C; Stratmann T; Van Ginderachter JA; Valledor AF
    Cancer Res; 2021 Feb; 81(4):968-985. PubMed ID: 33361391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists.
    Nomura S; Endo-Umeda K; Makishima M; Hashimoto Y; Ishikawa M
    ChemMedChem; 2016 Oct; 11(20):2347-2360. PubMed ID: 27690261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver X Receptor activation delays chondrocyte hypertrophy during endochondral bone growth.
    Sun MM; Beier F
    Osteoarthritis Cartilage; 2014 Jul; 22(7):996-1006. PubMed ID: 24852699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
    Morello F; Saglio E; Noghero A; Schiavone D; Williams TA; Verhovez A; Bussolino F; Veglio F; Mulatero P
    Atherosclerosis; 2009 Nov; 207(1):38-44. PubMed ID: 19426978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Expression of LXR-β in human gastric cancer tissue and the effect of GW3965 on the proliferation of gastric cancer cell line SGC-7901].
    Wang R; Li R; Wen Q; Peng K; Tan X; Chen Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):127-33. PubMed ID: 26932209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr
    Yu M; Amengual J; Menon A; Kamaly N; Zhou F; Xu X; Saw PE; Lee SJ; Si K; Ortega CA; Choi WI; Lee IH; Bdour Y; Shi J; Mahmoudi M; Jon S; Fisher EA; Farokhzad OC
    Adv Healthc Mater; 2017 Oct; 6(20):. PubMed ID: 28730752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LXR directly regulates glycosphingolipid synthesis and affects human CD4+ T cell function.
    Waddington KE; Robinson GA; Rubio-Cuesta B; Chrifi-Alaoui E; Andreone S; Poon KS; Ivanova I; Martin-Gutierrez L; Owen DM; Jury EC; Pineda-Torra I
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2.
    Secor McVoy JR; Oughli HA; Oh U
    J Neuroinflammation; 2015 Feb; 12():27. PubMed ID: 25889344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LXR agonist regulates the carcinogenesis of PCa via the SOCS3 pathway.
    Fu W; Yao J; Huang Y; Li Q; Li W; Chen Z; He F; Zhou Z; Yan J
    Cell Physiol Biochem; 2014; 33(1):195-204. PubMed ID: 24481266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.
    Kim KH; Lee GY; Kim JI; Ham M; Won Lee J; Kim JB
    J Lipid Res; 2010 Dec; 51(12):3425-33. PubMed ID: 20847297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimization and validation of mitochondria-based functional assay as a useful tool to identify BH3-like molecules selectively targeting anti-apoptotic Bcl-2 proteins.
    Long J; Liu L; Nikolovska-Coleska Z; Shangary S; Yi H; Wang S; Wang S
    BMC Biotechnol; 2013 May; 13():45. PubMed ID: 23705845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation.
    Pencheva N; Buss CG; Posada J; Merghoub T; Tavazoie SF
    Cell; 2014 Feb; 156(5):986-1001. PubMed ID: 24581497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver X receptor agonist GW3965 dose-dependently regulates lps-mediated liver injury and modulates posttranscriptional TNF-alpha production and p38 mitogen-activated protein kinase activation in liver macrophages.
    Wang YY; Dahle MK; Steffensen KR; Reinholt FP; Collins JL; Thiemermann C; Aasen AO; Gustafsson JA; Wang JE
    Shock; 2009 Nov; 32(5):548-53. PubMed ID: 19295476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthetic LXR agonists increase LDL in CETP species.
    Groot PH; Pearce NJ; Yates JW; Stocker C; Sauermelch C; Doe CP; Willette RN; Olzinski A; Peters T; d'Epagnier D; Morasco KO; Krawiec JA; Webb CL; Aravindhan K; Jucker B; Burgert M; Ma C; Marino JP; Collins JL; Macphee CH; Thompson SK; Jaye M
    J Lipid Res; 2005 Oct; 46(10):2182-91. PubMed ID: 16024916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells.
    Candelaria NR; Addanki S; Zheng J; Nguyen-Vu T; Karaboga H; Dey P; Gabbi C; Vedin LL; Liu K; Wu W; Jonsson PK; Lin JZ; Su F; Bollu LR; Hodges SE; McElhany AL; Issazadeh MA; Fisher WE; Ittmann MM; Steffensen KR; Gustafsson JÅ; Lin CY
    PLoS One; 2014; 9(9):e106289. PubMed ID: 25184494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.